Healthcare / Medical Care FacilitiesNasdaqGS
$14.19
+1.13 (+8.65%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 25%
FCF escenarios
weak_data · normalized FCF $-119.2M · quality 68.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
39/100
D
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.9B
P/E
N/A
•EV/EBITDA
N/A
•ROE
544.7%
↑Gross Margin
N/A
•Debt/Equity
-0.66
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2019–2025 · 6 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
—
FCF / Net income
0.55x
Latest source
Provider fallback
Margin decomposition
Último año: revenue — · net income $-287.9M · FCF $-157.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Net Income | $-287.9M | $-287.9M | $-155.1M | $-118.5M | $-91.5M | $-71.7M | $-60.3M | $-19.6M |
| EBITDA | $-285.6M | $-285.6M | $-148.8M | $-115.2M | $-90.8M | $-83.0M | $-51.3M | $-21.1M |
| EPS | -3.08 | -3.08 | -2.30 | -2.32 | -2.16 | -1.79 | -3.55 | -2.62 |
| Balance Sheet | ||||||||
| Debt/Equity | -0.66 | -0.66 | 0.21 | 0.15 | 0.01 | — | — | — |
| Current Ratio | 3.32 | 3.32 | — | — | — | — | — | — |
| Cash Flow | ||||||||
| Free Cash Flow | $-157.2M | $-157.2M | $-119.2M | $-97.4M | $-106.0M | $-68.1M | $-41.5M | $-18.0M |
| Returns | ||||||||
| ROE | 544.7% | 544.7% | -100.3% | -52.5% | -50.5% | -25.2% | -30.7% | 64.5% |
| Valuation | ||||||||
| P/B | — | — | 1.94 | 2.67 | 1.71 | — | — | — |
| Growth & Yield | ||||||||
| EPS Growth | -33.9% | -33.9% | 0.9% | -7.4% | — | 49.6% | -35.5% | — |
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+241.1%
Start / end P/E
n/dx → n/dx
EPS bridge
-2.30 → -3.08
Residual
+241.1%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.